logo-loader
viewBoundless Bio

Boundless Bio takes big steps forward filling out their staff

Boundless Bio CEO Zachary Hornby sat down with Proactive’s Christine Corrado at BIO CEO in New York. is a biotechnology company focused on interrogating a novel area of cancer biology, extrachromosomal DNA  to deliver transformative therapies to patients with previously intractable cancers.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

CB Therapeutics achieved the successful biosynthesis of psilocybin, psilocin

CB Therapeutics CEO Sher Butt joined Steve Darling with news the company has recently hit another milestone finding, in early testing, the analysis of raw analytical samples has shown the biosynthetic process of psilocybin, psilocin and related tryptamine-based compounds to be significantly more...

10 minutes ago

2 min read